Podcasts about clinically

This week on Inspire Change...Gunter is opening up the discussion about healing as a lifelong journey navigating setbacks and growth.  #InspireChange #Philosophy #Science #Reflection #Contemplation #SelfDevelopment #Masculinity #MakingGoodMenGreat #stoicism This week we are launching some partnerships with some ad sponsors that promote well-being, wellness and natural products. This week we would like to introduce you to More Labs.  More Labs' Morning Recovery is the #1 alcohol recovery supplement that helps you wake up clear-headed and refreshed. Clinically proven and trusted by thousands, with 20M+ bottles sold and a 4.9-star rating, it works. Try it risk-free! Enjoy an exclusive discount with our promo code https://www.morelabs.com/discount/INSPIRECHANGE Our code will be applied to your cart and you get a discount at any of the products at MoreLabs.com Their products are loaded with super ingredients—Milk Thistle, Prickly Pear, Red Ginseng, Electrolytes, and B Vitamins. It is Developed with top scientists—including Dr. Fu Chen, a former FDA expert in supplement absorption. MoreLabs products work better than sports drinks—targets toxin buildup and nutrient loss, not just dehydration. Their products are a clean formula—no artificial colors, sweeteners, or preservatives.  It is also portable & TSA-friendly—perfect for travel, work, or big nights out.Our gratitude this week goes out to our  listeners, We thank YOU for tuning in and promoting positive social change.  This makes you a part of Gunter's efforts in transforming not only men's lives but lives in general and we are grateful you have joined us.  This week we are taking a look at the Global Listeners List and for the FIRST time we would like to share our gratitude with our listeners in Iraq.  Thankyou  Baghdad & Nineveh (Nin-uh-vuh) for bringing Iraq on to the list at #10. CONGRATULATIONS!!!  We appreciate your efforts of supporting positive social change!I, DeVonna Prinzi the Co-Exec Producer and our Show-runner Miranda Spigener-Sapon sincerely thank you and ask that you please take the time to like, follow, subscribe, and share as your efforts make a difference to everyone here at Inspire Change with Gunter.   Please remember If you want to share your story of social change, feel free to reach out  to the show directly. Please see the show-notes for our contact information.  As always thank you to each and every one of our listeners, and most importantly please keep Inspiring positive social change.Become a supporter of this podcast: https://www.spreaker.com/podcast/inspire-change-with-gunter--3633478/support.Gunter Swoboda and Lorin Josephson's neo-noir/supernatural thriller novel Amulets of Power, Book I A Brian Poole Mystery is officially ON SALE EVERYWHERE you like to get book, but if you want a discount please consider ording direct. ANY LISTENER who order's direct will get a surprise gift. https://shop.ingramspark.com/b/084?params=3RoOA6kVQ7ZgmqSK9LdnvNyDAZZFsg9IMaLUaprPgXKMake sure you LIKE SUBSCRIBE & FOLLOW our new Official YouTube Channel of Video Shorts series: https://www.youtube.com/@InspireChangewithGunterSwoboda/videos where we will be adding new videos and content every week from Gunter and our guests.  https://www.youtube.com/@InspireChangewithGunterSwoboda/videos

Are you low in glutathione? Feeling sluggish, inflamed, or more sensitive to toxins than you used to be? Maybe you're catching every bug that goes around or noticing your recovery just isn't what it used to be. Today on the Naturally Nourished Podcast, we're talking about the body's master antioxidant, glutathione, and why it's essential for immune resilience, detoxification, energy, and longevity. We'll unpack what glutathione is, why modern life so easily depletes it, and how low levels have been linked to everything from fatigue and joint pain to accelerated aging and chronic disease. Plus, we'll share simple strategies to help you raise your levels naturally and introduce our newly reformulated Cellular Antiox, now featuring NAC, Setria® glutathione, and broccoli seed extract for enhanced cellular protection and glutathione production. Use the code CELLULAR15 to save 15% off our exciting reformulation of Cellular Antiox! Also in this episode:  What is glutathione and what does it do? Episode 325 All About Glutathione Trends of deficiency Micronutrient Panel How the body produces glutathione Cysteine Whey Protect Glycine Pure Collagen Relax and Regulate Glutamate GI Lining Support Do we store glutathione and does it need to be replenished? How to increase glutathione  Sulfur rich veggies Modulation of plasma antioxidant levels, glutathione S‐transferase activity and DNA damage in smokers following a single portion of broccoli: a pilot study Bone broth FOND Bone Broth use code ALIMILLERRD When to supplement with glutathione Will supplementation make my body stop producing it on its own? NEW Cellular Antiox reformulation A 2015 randomized, double-blind, placebo-controlled study published in the European Journal of Nutrition showed that 250–1000 mg of Setria daily for 6 months significantly increased glutathione levels in whole blood, red blood cells, and lymphocytes. Per 2 Capsules: Setria® Glutathione (250 mg): Clinically studied, reduced form, ready to use N-Acetylcysteine (1,000 mg): A powerful precursor, provides cysteine to fuel internal glutathione production Broccoli Seed Extract 40mg (2mg glucoraphanin): Activates Nrf2 pathway, upregulates endogenous antioxidant production, including glutathione Vitamin B6 (5 mg): Essential cofactor for amino acid metabolism and methylation, supports efficient detox and glutathione recyclingNew bovine gelatin capsule with silica as an added feature! Comparison to liposomal and IV glutathione How to dose 1 capsule twice daily for wellness 2 capsules 2-3 times daily for illness or infection Making Medicinal Honey   This episode is sponsored by: This episode is sponsored by Wild Foods, a company that puts quality, sustainability, and health first in all of their products. They have everything from coffee to turmeric to medicinal mushrooms, and every single product is painstakingly sourced from small farms around the globe. They take their mission seriously to fix the broken food system, and believe real food is medicine. They've partnered with us to give you guys an exclusive discount, so use the code ALIMILLERRD for 12% off your order at WildFoods.co! 

Catholics. During a near-death experience in 2017, Susan merged with an unnamable “God” and has mentored awakening women since.She graduated from Hamilton College with a Bachelor of Arts in Cultural Anthropology. Her work has appeared in Dance Magazine, FOLIO, Burningword, and Evening Street Review.Become a supporter of this podcast: https://www.spreaker.com/podcast/next-level-soul-podcast-with-alex-ferrari--4858435/support.

Airsupra is a combination inhaler that contains albuterol and budesonide, approved for as-needed use in adults with asthma. It represents the first rescue inhaler to combine a short-acting beta-2 agonist (SABA) with an inhaled corticosteroid (ICS) in a single device. The albuterol component provides rapid bronchodilation by relaxing airway smooth muscle, while budesonide works to reduce airway inflammation and mucus production. This dual mechanism allows Airsupra to not only relieve acute bronchoconstriction but also address the underlying inflammatory process that contributes to asthma exacerbations. Clinically, Airsupra is indicated for as-needed treatment or prevention of bronchoconstriction in adults with asthma, but it is not approved for COPD. The typical dosing is two inhalations as needed, with a maximum of six doses (12 inhalations) in a 24-hour period. The rationale for its use aligns with recent asthma guideline updates, which emphasize minimizing SABA-only use because it fails to address inflammation and may contribute to worse outcomes over time. Common adverse effects include tremor, nervousness, tachycardia, and hypokalemia from albuterol, as well as oral thrush and hoarseness from budesonide. Patients should rinse and spit after each use to reduce the risk of oral candidiasis. Drug interactions can occur with non-selective beta-blockers, which may blunt albuterol's effects. CYP3A4 also plays a role in budesonide metabolism. Systemic absorption typically isn't too much of an issue with infrequent use.

This week on Inspire Change...Gunter is ad-libbing as we wrap up the year. #InspireChange #Philosophy #Science #Reflection #Contemplation #SelfDevelopment #Masculinity #MakingGoodMenGreat #stoicism This week we are launching some partnerships with some ad sponsors that promote well-being, wellness and natural products. This week we would like to introduce you to More Labs.  More Labs' Morning Recovery is the #1 alcohol recovery supplement that helps you wake up clear-headed and refreshed. Clinically proven and trusted by thousands, with 20M+ bottles sold and a 4.9-star rating, it works. Try it risk-free! Enjoy an exclusive discount with our promo code https://www.morelabs.com/discount/INSPIRECHANGE Our code will be applied to your cart and you get a discount at any of the products at MoreLabs.com Their products are loaded with super ingredients—Milk Thistle, Prickly Pear, Red Ginseng, Electrolytes, and B Vitamins. It is Developed with top scientists—including Dr. Fu Chen, a former FDA expert in supplement absorption. MoreLabs products work better than sports drinks—targets toxin buildup and nutrient loss, not just dehydration. Their products are a clean formula—no artificial colors, sweeteners, or preservatives.  It is also portable & TSA-friendly—perfect for travel, work, or big nights out.Our gratitude this week goes out to our  listeners, We thank YOU for tuning in and promoting positive social change.  This makes you a part of Gunter's efforts in transforming not only men's lives but lives in general and we are grateful you have joined us.   This week we are taking a look at the USA's Top Ten Listeners List and would like to share our gratitude with our listeners in Atlanta for bringing Georgia  all the way to the top at #1, as you have have been steadily climbing the chart in your efforts of supporting positive social change. CONGRATULATIONS!!!  you made it to #1! I, DeVonna Prinzi the Co-Exec Producer and our Show-runner Miranda Spigener-Sapon sincerely thank you and ask that you please take the time to like, follow, subscribe, and share as your efforts make a difference to everyone here at Inspire Change with Gunter.    Please remember If you want to share your story of social change, feel free to reach out  to the show directly. Please see the show-notes for our contact information.  As always thank you to each and every one of our listeners, and most importantly keep Inspiring positive social change.Become a supporter of this podcast: https://www.spreaker.com/podcast/inspire-change-with-gunter--3633478/support.Gunter Swoboda and Lorin Josephson's neo-noir/supernatural thriller novel Amulets of Power, Book I A Brian Poole Mystery is officially ON SALE EVERYWHERE you like to get book, but if you want a discount please consider ording direct. ANY LISTENER who order's direct will get a surprise gift. https://shop.ingramspark.com/b/084?params=3RoOA6kVQ7ZgmqSK9LdnvNyDAZZFsg9IMaLUaprPgXKMake sure you LIKE SUBSCRIBE & FOLLOW our new Official YouTube Channel of Video Shorts series: https://www.youtube.com/@InspireChangewithGunterSwoboda/videos where we will be adding new videos and content every week from Gunter and our guests.  https://www.youtube.com/@InspireChangewithGunterSwoboda/videos

Erik Meira joined Noah for the second time on Forward Physio to discuss the principles of early rehab for Achilles rupture repairs.Erik is a physical therapist and educator who is well known for being the first person to start a podcast related to physical therapy back in 2011. Clinically, Erik mainly works with collegiate and professional level athletes. He has authored several articles and textbook chapters, has been a keynote speaker at large conferences, and hosts a variety of courses both in person and online. He is the owner of TheSciencePT.com and the creator of the Elite Rehab Conferences, which currently include conferences on basketball, football, soccer, and hockey. Fun fact: Erik is also a pilot! Enjoy!https://thesciencept.com/https://eliterehabconferences.com/Erik's TwitterErik's Instagram----Noah's InstagramNoah's WebsiteFor questions and business inquiries: noahmandelphysio@gmail.com

Red light therapy has started to gain traction in popular culture. From sports medicine recovery to beauty treatments, more and more people are starting to catch on to the benefits of using red light. But why does red light therapy work? And what are its science-backed benefit? On today's show, we're going to dive into the science of red light therapy. You're going to learn how light therapy can help reduce pain, enhance skin quality, improve the symptoms of certain disorders, and so much more! You're also going to learn about other types of light therapy, like ultraviolet and green light therapy. We're going to discuss the health benefits of getting adequate sunlight, why human biology is so responsive to input from light sources, and how to integrate more light into your routine. Enjoy!   In this episode you'll discover:  How red light therapy can help reduce pain. (0:21) The link between red light exposure and wrinkle reduction. (1:22) Which bacteria has been shown to be reduced by far UV light. (2:09) How red light therapy can help with muscle growth. (2:45) The science behind why the human body is so responsive to light. (5:09) How your circadian timing system works. (5:47) The #1 influencer of your circadian clocks. (6:26) How mitochondria respond to red light therapy. (7:38) A fascinating study on hypothyroidism and red light therapy. (11:19) The link between light therapy and fat loss. (17:28) What the ultimate source of light therapy is. (23:09)  Items mentioned in this episode include:  ⁠Thelumebox.com/model⁠  -  Experience the next-level benefits of red light therapy at home? Enjoy an exclusive $260 off the premium LUMEBOX red light therapy system, designed to boost recovery, skin health, and overall vitality. Be sure you are subscribed to this podcast to automatically receive your episodes:   ⁠Apple Podcasts⁠ ⁠Spotify⁠ ⁠Soundcloud⁠ ⁠Pandora⁠ ⁠YouTube⁠   This episode of The Model Health Show is brought to you by Lumebox. Clinically-designed to deliver both red (660 nm) and near-infrared (850 nm) wavelengths in one sleek handheld device.Independently lab-tested for performance: more coverage, higher irradiance, greater effect. Perfect for skin health, pain support, recovery and overall vitality — in your routine, on your terms. Use this link to claim your discount: ⁠thelumebox.com/model⁠ to claim or $260 off your device.   Learn more about your ad choices. Visit megaphone.fm/adchoices

Host: Ryan Quigley New research presented at the 2025 American College of Rheumatology Convergence highlights a critical link between adverse childhood experiences and mental health outcomes in adolescents with childhood-onset systemic lupus erythematosus (cSLE). In this AudioAbstract, Ryan Quigley explores the findings, the implications for trauma-informed care, and the need to assess psychosocial history in managing cSLE.

Galen Clavio and Scott Caulfield recap Indiana's 38–13 win over Michigan State — a dominant, businesslike homecoming victory. They break down Fernando Mendoza's near-perfect day, IU's offensive balance, the defense's steady control, and how the Hoosiers continue proving they belong among the nation's best.Presented by Homefield Apparel.

In this episode of Real Life Pharmacology, we take a deep dive into daptomycin, a lipopeptide antibiotic primarily used for serious Gram-positive infections, including MRSA and VRE. Daptomycin works by binding to bacterial cell membranes in a calcium-dependent manner, causing rapid depolarization and cell death. One key limitation is that daptomycin should never be used for pneumonia because pulmonary surfactant inactivates the drug. Clinically, it's often reserved for bacteremia, endocarditis, or complicated skin and soft tissue infections. From a pharmacokinetic standpoint, daptomycin is given intravenously and primarily eliminated unchanged by the kidneys, so dose adjustments are necessary in renal impairment. Monitoring creatine kinase (CK) levels is crucial, as one of the major adverse effects is myopathy and, rarely, rhabdomyolysis. Patients on statins have a higher risk of muscle toxicity, and clinicians should consider holding or monitoring statin therapy closely. Eosinophilic pneumonia is another rare but serious adverse reaction that can develop after prolonged therapy. Daptomycin has minimal drug interactions, making it an appealing option when other agents pose risks. Overall, it's a powerful antibiotic when used appropriately, but requires careful monitoring for muscle and respiratory-related side effects.

For The Other Side NDE Videos Visit ▶️ youtube.com/@TheOtherSideNDEYT Purchase our book on Amazon

Steven Noack is a quantum healer and zero point healing practitioner. At a very young age Steve was struck by a motor vehicle and this event bio electrically connected him to the quantum field. During Steve's near death experience he experienced sitting with a being comprised solely of light. The being of light revealed to Steve the quantum field and its connection to humanities healing contained in their divine blueprint.Steve's gift enables him to stimulate emotional and physical healing from any distance through quantum entanglement and photonics. Every living being emits Biophotons or weak radiation generated as a bio electrical field and this is what links all living beings to collective consciousness. By using his unique gifts he is able to create a zero point field or ground state for the bio electrical nervous system and open pathways for healing.Steve began using his gifts to give back to humanity by first studying Usui Reiki over ten years ago and has only grown from there. He now teaches heals and coaches clients from around the world. Steve works with hundreds of clients of all ages and backgrounds, guiding them on their journey of freedom from pain and trauma. Steve has a wide range of experience healing both spiritual and physical ailments from cancerous tumors to common injuries.Become a supporter of this podcast: https://www.spreaker.com/podcast/next-level-soul-podcast-with-alex-ferrari--4858435/support.

Cefepime is a fourth-generation cephalosporin antibiotic with broad-spectrum activity against both gram-positive and gram-negative organisms, including Pseudomonas aeruginosa. It works by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins, leading to cell lysis and death. Clinically, cefepime is commonly used in hospital settings for serious infections such as pneumonia, febrile neutropenia, urinary tract infections, skin infections, and intra-abdominal infections. It's typically administered intravenously, with doses often ranging from 1 to 2 grams every 8 to 12 hours depending on the indication and renal function. From a pharmacokinetic standpoint, cefepime is primarily renally eliminated, so dose adjustments are required in patients with impaired kidney function. Failure to reduce the dose appropriately can lead to neurotoxicity — one of the key adverse effects associated with cefepime — manifesting as encephalopathy, confusion, myoclonus, or seizures, particularly in elderly or renally impaired patients. Common side effects include gastrointestinal upset and rash. Cefepime has relatively limited drug interactions, though concurrent nephrotoxic agents can increase the risk of renal injury.

Nearly all hiring managers are using AI to help narrow the field of job candidates... Should job seekers be using the same tools to narrow the field of positions to apply for? (at 13:31) --- Throwback Thursday: Healthcare is at the center of the government shutdown - Clinically, America's system is the finest in the world – so why are so many patients complaining? A closer look at the disconnect between doctors, hospitals and the people they serve (at 21:33) --- Around Town: The All Developmental Differences and Abilities Parent Teacher Community Organization of Hancock County - aka ADDAPTCO - is hosting their 9th annual Fall Fest this weekend (at 44:27)

Discover how clinically integrated networks (CINs) empower physicians, specialists, and pharmacy partners to deliver coordinated, patient-centered care. In this episode, Debi Hueter of WakeMed Key Community Care joins Rebecca Grandy from CHESS Health Solutions to discuss collaboration, trust, and innovation in value-based care. Learn how team-based care models reduce administrative burden, improve outcomes, and support providers at the top of their license.

In this episode, Moderator Dr. Scott Weiner learns how Dr. Sarah E. Wakeman's innovative role unites diverse stakeholders to change both culture and practice in SUD care. We explore best practices for medication for opioid use disorder (MOUD), the development of unified IT tools, and the fine balance between clinical support and alert fatigue. Dr. Wakeman highlights the importance of data and quality dashboards, plus how Medicaid and state funding are leveraged to sustain impactful initiatives. The episode offers practical inspiration, showing how collaboration and the right incentives can drive value—and save lives.  What You'll Learn Strategies for building system-wide, holistic SUD initiatives. How to engage stakeholders across health systems, from clinicians to IT to state agencies. Best practices for developing and updating MOUD order sets. Approaches to increasing provider comfort with life-saving opioid treatments. The balance of clinical decision support and alert fatigue. The role of data dashboards in tracking SUD outcomes and quality measures. How to leverage Medicaid and state funds to support and expand treatment resources. Insights into risk contracts, funding streams, and statewide efforts to prevent overdose deaths. Why this challenging work is both challenging and rewarding!  MODERATOR: Scott Weiner, MD, MPH, FAAEM, FACEP, FASAM Emergency and Addiction Medicine Physician, Brigham and Women's Hospital Associate Professor, Harvard Medical School  Dr. Weiner is the McGraw Distinguished Chair in the Department of Emergency Medicine at Brigham and Women's Hospital and an Associate Professor of Emergency Medicine at Harvard Medical School. He is board-certified in emergency medicine and addiction medicine. He is an active researcher, working on multiple projects that focus on prevention and treatment of opioid use disorder.  GUEST: Sarah Elizabeth Wakeman, MD Medical Director for Substance Use Disorder at Mass General Brigham Medical Director for the Mass General Hospital Substance Use Disorder Initiative Program director of the Mass General Addiction Medicine fellowship Associate Professor of Medicine at Harvard Medical School  Sarah E. Wakeman, MD is the Senior Medical Director for Substance Use Disorder at Mass General Brigham in the Office of the Chief Medical Officer, Medical Director for the Mass General Hospital Program for Substance Use & Addiction Services, Program Director of the Mass General Addiction Medicine fellowship, and an Associate Professor of Medicine at Harvard Medical School. She received her A.B. from Brown University and her M.D. from Brown Medical School. She completed residency training in internal medicine and served as Chief Medical Resident at Mass General Hospital. She is a diplomate and fellow of the American Board of Addiction Medicine and board certified in Addiction Medicine by the American Board of Preventive Medicine. Clinically she provides specialty addiction and general medical care in the inpatient and outpatient setting at Mass General Hospital and the Mass General Charlestown Health Center. Her research interests include integrated substance use disorder treatment in general medical settings, low threshold treatment models, and opioid use disorder treatment. 

The newly signed One Big Beautiful Bill Act is reshaping the healthcare landscape, with ripple effects for providers, payers, and patients. From Medicaid coverage shifts and rural hospital funding challenges to stricter ACA rules, expanded value-based care, and mandatory risk models, the implications are broad and far-reaching. In this episode of Value-Based Care Insights, host Daniel J. Marino speaks with Ben Sparks, President of Bryan Health Connect, a clinically integrated network, to examine four critical areas leaders must prepare for: projected Medicaid losses, financial pressures on hospitals, new insurance access rules, and the wider fiscal and political fallout across states. Drawing on Bryan Health Connect's experience, Ben shares practical takeaways to help leaders adapt to the new law.

The newly signed One Big Beautiful Bill Act is reshaping the healthcare landscape, with ripple effects for providers, payers, and patients. From Medicaid coverage shifts and rural hospital funding challenges to stricter ACA rules, expanded value-based care, and mandatory risk models, the implications are broad and far-reaching. On this episode Dan speaks with Ben Sparks, President of Bryan Health Connect, a clinically integrated network, to examine four critical areas leaders must prepare for: projected Medicaid losses, financial pressures on hospitals, new insurance access rules, and the wider fiscal and political fallout across states. Drawing on Bryan Health Connect's experience, Ben shares practical takeaways to help leaders adapt to the new law. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Midodrine is an oral alpha-1 agonist most commonly used for the treatment of symptomatic orthostatic hypotension. Its mechanism of action is through peripheral vasoconstriction, which helps increase blood pressure. Because of its short duration of action, it is typically dosed three times daily, with the last dose recommended in the late afternoon to reduce the risk of hypertension at night. Clinically, midodrine is often considered when non-pharmacologic strategies for orthostatic hypotension (such as increased salt/fluid intake, compression stockings, or physical counter-maneuvers) are not enough. Pharmacists should also be aware of prescribing cascades—such as urinary retention leading to tamsulosin initiation—that can arise when midodrine is used. Midodrine is generally not metabolized through cytochrome P450 pathways, so significant drug–drug interactions are less common. However, caution should be exercised with other agents that can raise blood pressure (like decongestants) or slow the heart rate (such as beta-blockers). Monitoring parameters include blood pressure, pulse, symptoms of urinary retention, and the patient's overall response to therapy.

Clinically Dead, Walking with Jesus for 44 Hours - NDE Miracle!: Robert Marshall. When Robert Marshall went into cardiac arrest, he was clinically dead—no heartbeat, no breath—for 44 hours. During that time, he says he was fully conscious in heaven, with Jesus. What he witnessed was beyond anything imaginable: harmonic trees, divine light, and a mission he didn't want but ultimately accepted.

For The Other Side NDE Videos Visit ▶️ youtube.com/@TheOtherSideNDEYT Purchase our book on Amazon

Revefenacin (brand name Yupelri) is a long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It works by blocking muscarinic receptors, particularly the M3 subtype, in airway smooth muscle. This antagonism reduces cholinergic bronchoconstriction and leads to sustained bronchodilation. Unlike short-acting anticholinergics such as ipratropium, revefenacin provides 24-hour bronchodilation with once-daily dosing. One of the distinguishing features of revefenacin is that it is the first nebulized LAMA approved for COPD maintenance therapy. Many patients with advanced COPD, physical limitations, or difficulty using handheld inhalers benefit from a nebulized formulation, as it allows medication delivery without requiring hand-breath coordination or a forceful inhalation. This makes it a useful option for patients with poor inhaler technique or those transitioning from hospital care. Pharmacokinetically, revefenacin is delivered via nebulization, with peak effects typically observed within a couple of hours. Importantly, systemic absorption is relatively low, but elderly patients or those with hepatic impairment may be more susceptible to anticholinergic side effects. Clinically, revefenacin improves lung function, reduces COPD symptoms, and can decrease exacerbation frequency. Common adverse effects include cough, dry mouth, constipation, and urinary retention. Caution is advised in patients with narrow-angle glaucoma or prostatic hyperplasia due to its antimuscarinic properties. Revefenacin is not intended for acute bronchospasm or rescue therapy—it is strictly for long-term, once-daily maintenance.

Two Onc Docs, hosted by Samantha A. Armstrong, MD, and Karine Tawagi, MD, is a podcast dedicated to providing current and future oncologists and hematologists with the knowledge they need to ace their boards and deliver quality patient care. Dr Armstrong is a hematologist/oncologist and assistant professor of clinical medicine at Indiana University Health in Indianapolis. Dr Tawagi is a hematologist/oncologist and assistant professor of clinical medicine at the University of Illinois in Chicago. In this episode, OncLive On Air® partnered with Two Onc Docs to feature a conversation about soft tissue sarcoma management. Drs Armstrong and Tawagi discussed that soft tissue sarcomas represent a rare and heterogeneous group of malignancies that arise from mesenchymal cells rather than epithelial cells and encompass several distinct histologic subtypes. They explained that although uncommon, these sarcomas are frequently emphasized in board examinations, partly because their management has historically been stable, though recent FDA approvals and ongoing research have expanded therapeutic options. They noted that risk factors may include prior radiation exposure, environmental agents, and viral infections. Additionally, they shared that chronic lymphedema is associated with angiosarcoma, whereas rare hereditary syndromes may predispose individuals to specific sarcoma subtypes.  Clinically, they explained that sarcomas may arise anywhere in the body, though many occur in the thigh, buttocks, or groin, typically presenting as painless, enlarging masses often mistaken for benign lesions. They emphasized that diagnosis requires core needle biopsy to preserve tissue architecture and that staging relies on MRI of the primary site and CT of the chest, given the strong predilection for pulmonary metastases. They also summarized the five subtypes of soft tissue sarcoma—synovial, clear cell, angiosarcoma, rhabdomyosarcoma, and epithelioid. They reported that the cornerstone of localized disease management is surgical resection, preferably limb-sparing when feasible, combined with radiation for larger or high-risk tumors. They also highlighted novel strategies like immunotherapy. For metastatic disease, they stated that surgical resection of pulmonary metastases can achieve durable remissions in select patients. 

Liang-Shun Lim, known professionally as Shin Lim, is a Canadian-American magician, recognized for his use of card manipulation and sleight of hand. He is known for elaborate close-up card magic routines, during which he remains silent with the tricks set to music. Anjelah Johnson-Reyes is an American actress, stand-up comedian, and former NFL cheerleader. She cheered for the Oakland Raiders early in her career. Johnson is best known for her roles as the fast food worker turned star Bon Qui Qui and the nail salon employee Mỹ Linh/Tammy on season 13 of MADtv. She also had a sold-out stand-up comedy tour called "Who Do I Think I Am?" that visited over 75 cities in North America. Bobbys World Merchandise from Retrokid: https://retrokid.ca/collections/bobbys-world Howie Mandel Does Stuff available on every Podcast Platform Visit the Official Howie Mandel Website for more: https://www.howiemandel.com/ Howie Mandel Does Stuff Merchandise available on Amazon.com here https://www.amazon.com/shop/howiemandeldoesstuff Join the "Official Howie Mandel Does Stuff" Reddit: https://www.reddit.com/r/HowieMandelPodcast/ Thanks to Our Sponsors: The Picket Protector Classic Harness Bundle is a simple, durable, lightweight bar and harness system that stops them from slipping through those pesky fence pickets. Give your dog the backyard playtime they deserve, while you enjoy the peace of mind knowing they're safe from slipping through the fence. Ditch the flimsy bumpers, forget the expensive fence upgrades, and head over to thepicketprotector.com and use the code 'HOWIE10' for 10% off. Oil Away's Waterless Concrete Cleaner is packed with Enzyme Infused Technology™ that eats petroleum stains for lunch, and a little goes a long way. We're talking oil, barbecue grease spills from when my buddies visit, even that stain that had been haunting my driveway for months! Plus, it's biodegradable and eco-friendly! Use the code 'HOWIE' to get a special offer at oilaway.us Geneomx's 5-day Liver & Gallbladder Cleanse — sounds intense, right? But it's like a spa day for your insides. Clinically studied ingredients and fancy words I can't pronounce, all working to help flush out built up toxins, support digestion, and give your liver the rest it deserves! Geneomx is proudly manufactured in the USA and for a limited time, they're offering free continental US shipping at Geneomx.com Say Hello to our house band Sunny and the Black Pack! Follow them here! YouTube: https://www.youtube.com/@BlackMediaPresents TikTok: https://www.tiktok.com/@blackmediapresents Spotify: https://open.spotify.com/artist/01uFmntCHwOW438t7enYOO?si=0Oc-_QJdQ0CrMkWii42BWA&nd=1&dlsi=a9792af062844b4f Facebook: https://www.facebook.com/SunnyAndTheBlackPack/ Instagram: https://www.instagram.com/blackmediapresents/ Twitch: https://www.twitch.tv/blackmediapresents Twitter: twitter.com/blackmedia @howiemandel @jackelynshultz @shinlimmagic @anjelahjohnson

You won't believe who we have on the podcast today. She's a Phillies fan and a Gritty stan

Multiple system atrophy is a rare, sporadic, adult-onset, progressive, and fatal neurodegenerative disease. Accurate and early diagnosis remains challenging because it presents with a variable combination of symptoms across the autonomic, extrapyramidal, cerebellar, and pyramidal systems. Advances in brain imaging, molecular biomarker research, and efforts to develop disease-modifying agents have shown promise to improve diagnosis and treatment. In this episode, Casey Albin, MD speaks with Tao Xie, MD, PhD, author of the article “Multiple System Atrophy” in the Continuum® August 2025 Movement Disorders issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Xie is director of the Movement Disorder Program, chief of the Neurodegenerative Disease Section in the department of neurology at the University of Chicago Medicine in Chicago, Illinois. Additional Resources Read the article: Multiple System Atrophy Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Full episode transcript available here Dr. Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Albin: Hello everyone, this is Dr Casey Albin. Today I'm interviewing Dr Tao Xie about his article on diagnosis and management of multiple system atrophy, which appears in the August 2025 Continuum issue on movement disorders. Welcome to the podcast, and please introduce yourself to our audience. Dr Xie: Thank you so much, Dr Albin. My name is Tao Xie, and sometimes people also call me Tao Z. I'm a mood disorder neurologist, professor of neurology at the University of Chicago. I'm also in charge of the mood disorder program here, and I'm the section chief in the neurodegenerative disease in the Department of Neurology at the University of Chicago Medicine. Thank you for having me, Dr Albin and Dr Okun and the American Academy of Neurology. This is a great honor and pleasure to be involved in this education session. Dr Albin: We are delighted to have you, and thank you so much for the thoughtful approach to the diagnosis and management. I really want to encourage our listeners to check out this article. You know, one of the things that you emphasize is multiple system atrophy is a fairly rare condition. And I suspect that clinicians and trainees who even have a fair amount of exposure to movement disorders may not have encountered that many cases. And so, I was hoping that you could just start us off and walk us through what defines multiple system atrophy, and then maybe a little bit about how it's different from some of the more commonly encountered movement disorders. Dr Xie: This is a really good question, Dr Albin. Indeed, MSA---multisystem atrophy----is a rare disease. It is sporadic, adult-onset, progressive, fatal neurodegenerative disease. By the name MSA, multisystem atrophy. Clinically, it will present with multiple symptoms and signs involving multiple systems, including symptoms of autonomic dysfunction and symptoms of parkinsonism, which is polyresponsive to the levodopa treatment; and the symptom of cerebellar ataxia, and symptom of spasticity and other motor and nonmotor symptoms. And you may be wondering, what is the cause- underlying cause of these symptoms? Anatomically, we can find the area in the basal ganglia striatonigral system, particularly in the putamen and also in the cerebellar pontine inferior, all of the nuclear area and the specific area involved in the autonomic system in the brain stem and spinal cord: all become smaller. We call it atrophy. Because of the atrophy in this area, they are responsible for the symptom of parkinsonism if it is involved in the putamen and the cerebral ataxia, if it's involved in the pons and cerebral peduncle and the cerebellum. And all other area, if it's involved in the autonomic system can cause autonomic symptoms as well. So that's why we call it multisystem atrophy. And then what's the underlying cellular and subcellular pathological, a hallmark that is in fact caused by misfolded alpha-synuclein aggregate in the oligodontia site known as GCI---glial cytoplasmic increasing bodies---in the cells, and sometimes it can also be found in the neuronal cell as well in those areas, as mentioned, which causes the symptom. But clinically, the patient may not present all the symptoms at the same time. So, based on the predominant clinical symptom, if it's mainly levodopa, polyresponsive parkinsonism, then we call it MSAP. If it's mainly cerebellar ataxia, then we call it MSAC. But whether we call it MSP or MSC, they all got to have autonomic dysfunction. And also as the disease progresses, they can also present both phenotypes together. We call that mixed cerebellar ataxia and parkinsonism in the advanced stage of the disease. So, it is really a complicated disease. The complexity and the similarity to other mood disorders, including parkinsonism and the cerebellar ataxia, make it really difficult sometimes, particularly at the early stages of disease, to differentiate one from the other. So, that was challenging not only for other professionals, general neurologists and even for some movement disorder specialists, that could be difficult particularly if you aim to make an accurate and early diagnosis. Dr Albin: Absolutely. That is such a wealth of knowledge here. And I'm going to distill it just a little bit just to make sure that I understand this right. There is alpha-synuclein depositions, and it's really more widespread than one would see maybe in just Parkinson's disease. And with this, you are having patients present with maybe one of two subtypes of their clinical manifestations, either with a Parkinson's-predominant movement disorder pattern or a cerebellar ataxia type movement disorder pattern. Or maybe even mixed, which really, you know, we have to make things quite complicated, but they are all unified and having this shared importance of autonomic features to the diagnosis. Have I got that all sort of correct? Dr Xie: Correct. You really summarize well. Dr Albin: Fantastic. I mean, this is quite a complicated disease. I would pose to you sort of a case, and I imagine this is quite common to what you see in your clinic. And let's say, you know, a seventy-year-old woman comes to your clinic because she has had rigidity and poor balance. And she's had several falls already, almost always from ground level. And her family tells you she's quite woozy whenever she gets up from the chair and she tends to kind of fall over. But they noticed that she's been stiff,and they've actually brought her to their primary care doctor and he thought that she had Parkinson's disease. So, she started levodopa, but they're coming to you because they think that she probably needs a higher dose. It's just not working out very well for her. So how would you sort of take that history and sort of comb through some of the features that might make you more concerned that the patient actually has undiagnosed multiple systems atrophy? Dr Xie: This is a great case, because we oftentimes can encounter similar cases like this in the clinic. First of all, based on the history you described, it sounds like an atypical parkinsonism based on the slowness, rigidity, stiffness; and particularly the early onset of falls, which is very unusual for typical Parkinson disease. It occurs too early. If its loss of balance, postural instability, and fall occurred within three years of disease onset---usually the motor symptom onset---then it raises a red flag to suspect this must be some atypical Parkinson disorders, including multiple system atrophy. Particularly, pou also mentioned that the patient is poorly responsive to their levodopa therapy, which is very unusual because for Parkinson disease, idiopathic Parkinson disease, we typically expect patients would have a great response to the levodopa, particularly in the first 5 to 7 years. So to put it all together, this could be atypical parkinsonism, and I could not rule out the possibility of MSA. Then I need to check more about other symptoms including autonomic dysfunction, such as orthostatic hypertension, which is a blood pressure drop when the patient stands up from a lying-down position, or other autonomic dysfunctions such as urinary incontinence or severe urinary retention. So, in the meantime, I also have to put the other atypical Parkinson disorder on the differential diagnosis, such as PSP---progressive supranuclear palsy---and the DLBD---dementia with Lewy body disease.---Bear this in mind. So, I want to get more history and more thorough bedside assessment to rule in or rule out my diagnosis and differential diagnosis. Dr Albin: That's super helpful. So, looking for early falls, the prominence of autonomic dysfunction, and then that poor levodopa responsiveness while continuing to sort of keep a very broad differential diagnosis? Dr Xie: Correct. Dr Albin: One of the things that I just have to ask, because I so taken by this, is that you say in the article that some of these patients actually have preservation of smell. In medical school, we always learn that our Parkinson's disease patients kind of had that early loss of smell. Do you find that to be clinically relevant? Is that- does that anecdotally help? Dr Xie: This is a very interesting point because we know that the loss of smelling function is a risk effect, a prodromal effect, for the future development of Parkinson disease. But it is not the case for MSA. Strange enough, based on the literature and the studies, it is not common for the patient with MSA to present with anosmia. Some of the patients may have mild to moderate hyposmia, but not to the degree of anosmia. So, this is why even in the more recent diagnosis criteria, the MDS criteria published 2022, it even put the presence of anosmia in the exclusion criteria. So, highlight the importance of the smell function, which is well-preserved for the majority in MSA, into that category. So, this is a really interesting point and very important for us, particularly clinicians, to know the difference in the hyposmia, anosmia between the- we call it the PD, and the dementia Lewy bodies versus MSA. Dr Albin: Fascinating. And just such a cool little tidbit to take with us. So, the family, you know, you're talking to them and they say, oh yes, she has had several fainting episodes and we keep taking her to the primary care doctor because she's had urinary incontinence, and they thought maybe she had urinary tract infections. We've been dealing with that. And you're sort of thinking, hm, this is all kind of coming together, but I imagine it is still quite difficult to make this diagnosis based on history and physical alone. Walk our listeners through sort of how you're using MRI and DAT scan and maybe even some other biomarkers to help sort of solidify that diagnosis. Dr Xie: Yeah, that's a wonderful question. Yeah. First of all, UTI is very common for patients with MSA because of urinary retention, which puts them into a high risk of developing frequent UTI. That, for some patients, could be the very initial presentation of symptoms. In this case, if we check, we say UTI is not present or UTI is present but we treat it, then we check the blood pressure and we do find also hypertension---according to new diagnosis criteria, starting drop is 20mm mercury, but that's- the blood pressure drop is ten within three minutes. And also, in the meantime the patients present persistent urinary incontinence even after UTI was treated. And then the suspicion for MS is really high right at this point. But if you want increased certainty and a comfortable level on your diagnosis, then we also need to look at the brain MRI mark. This is a required according to the most recent MDS diagnosis criteria. The presence of the MRI marker typical for MSA is needed for the diagnosis of clinically established MSA, which holds the highest specificity in the clinical diagnosis. So then, we have- we're back to your question. We do need to look at the brain MRI to see whether evidence suggestive of atrophy around the putamen area, around the cerebellar pontine inferior olive area, is present or not. Dr Albin: Absolutely. That's super helpful. And I think clinicians will really take that to sort of helping to build a case and maybe recognizing some of this atypical Parkinson's disease as a different disease entity. Are there any other biomarkers in the pipeline that you're excited about that may give us even more clarity on this diagnosis? Dr Xie: Oh, yeah. This is a very exciting area. In terms of biomarker for the brain imaging, particularly brain MRI, in fact, today there's a landmark paper just published in the Java Neurology using AI, artificial intelligence or machine learning aid, diagnoses a patient with parkinsonism including Parkinson's disease, MSA, and PSP, with very high diagnostic accuracy ranging from 96% to 98%. And some of the cases even were standard for autopsy, with pathological verification at a very high accurate rate of 93.9%. This is quite amazing and can really open new diagnosis tools for us to diagnose this difficult disease; not only in an area with a bunch of mood disorder experts, but also in the rural area, in the area really in need of mood disorder experts. They can provide tremendous help to provide accurate, early diagnosis. Dr Albin: That's fantastic and I love that, increasing the access to this accurate diagnosis. What can't artificial intelligence do for us? That's just incredible. Dr Xie: And also, you know, this is just one example of how the brain biomarker can help us. Theres other---a fluid biomarker, molecular diagnostic tools, is also available. Just to give you an example, one thing we know over the past couple years is skin biopsy. Through the immunofluorescent reaction, we can detect whether the hallmark of abnormally folded, misfolded, and the phosphorate, the alpha-synuclein aggregate can be found just by this little pinch of skin biopsy. Even more advanced, there's another diagnosis tool we call the SAA, we call the seizure amplification assay, that can even help us to differentiate MSA from other alpha-synucleinopathy, including Parkinson disease and dementia with Lewy bodies. If we get a little sample from CSF, spinal cerebral fluids, even though this is probably still at the early stage, a lot of developments still ongoing, but this, this really shows you how exciting this area is now. We're really in a fast forward-moving path now. Dr Albin: It's really incredible. So, lots coming down the track in, sort of, MRI, but also with CSF diagnosis and skin biopsies. Really hoping that we can hone in some of those tools as they become more and more validated to make this diagnosis. Is that right? Dr Xie: Correct. Dr Albin: Amazing. We can talk all day about how you manage these in the clinic, and I really am going to direct our listeners to go and read your fantastic article, because you do such an elegant job talking about how this takes place in a multidisciplinary setting, if at all possible. But as a neurointensivist, I was telling you, we have so much trouble in the hospital. We have A-lines, and we have the ability to get rapid KUBs to look at Ilias, and we can have many people as lots of diagnosis, and we still have a lot of trouble treating autonomiclike symptoms. Really, really difficult. And so, I just wanted to kind of pick your brain, and I'll start with just the one of orthostatic hypotension. What are some of the tips that you have for, you know, clinicians that are dealing with this? Because I imagine that this is quite difficult to do without patients. Dr Xie: Exactly. This is indeed a very difficult symptom to deal with, particularly at an outpatient setting. But nowadays with the availability of more medication---to give an example, to treat patients with orthostatic hypertension, we have not only midodrine for the cortisol, we also have droxidopa and several others as well. And so, we have more tools at hand to treat the patient with orthostatic hypertension. But I think the key thing here, particularly for us to the patient at the outpatient setting: we need to educate the patient's family well about the natural history of the disease course. And we also need to tell them what's the indication and the potential side effect profile of any medication we prescribe to them so that they can understand what to expect and what to watch for. And in the meantime, we also need to keep really effective and timely communication channels, make sure that the treating physician and our team can be reached at any time when the patient and family need us so that we can be closely monitoring, their response, and also monitoring potential side effects as well to keep up the quality of care in that way. Dr Albin: Yeah, I imagine that that open communication plays a huge role in just making sure that patients are adapting to their symptoms, understanding that they can reach out if they have refractory symptoms, and that- I imagine this takes a lot of fine tuning over time. Dr Xie: Correct. Dr Albin: Well, this has just been such a delight to get to talk to you. I really feel like we could dive even deeper, but I know for the sake of time we have to kind of close out. Are there any final points that you wanted to share with our listeners before we end the interview? Dr Xie: I think for the patients, I want them to know that nowadays with advances in science and technology, particularly given a sample of rapid development in the diagnostic tools and the multidisciplinary and multisystemic approach to treatment, nowadays we can make an early and accurate diagnosis of the MSA, and also, we can provide better treatment. Even though so far it is still symptomatically, mainly, but in the near future we hope we can also discover disease-modifying treatment which can slow down, even pause or prevent the disease from happening. And for the treating physician and care team professionals, I just want them to know that you can make a difference and greatly help the patient and the family through your dedicated care and also through your active learning and innovative research. You can make a difference. Dr Albin: That's amazing and lots of hope for these patients. Right now, you can provide really great care to take care of them, make an early and accurate diagnosis; but on the horizon, there are really several things that are going to move the field forward, which is just so exciting. Again today, I've been really greatly honored and privileged to be able to talk to Dr Tao Xie about his article on diagnosis and management of multiple system atrophy, which appears in the August 2025 Continuum issue on movement disorders. Be sure to check out Continuum Audio episodes for this and other issues. And thank you again to our listeners for joining us today. Dr Xie: Thank you so much for having me. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

  Interviewees: Tom Pisano, MD PhD and Laura Ashley Stein, MD, MS, Ed. Interviewer: Lisa Meeks, PhD, MA Description: In Episode 111, Dr. Lisa Meeks talks with Dr. Tom Pisano (former Penn neurology resident; now neuro-hospital medicine and neuro-immunology fellow) and Dr. Laura Stein (Adult Neurology Program Director at Penn) about building an accessible neurology residency for a physician who uses a wheelchair—and how trust, planning, and culture made it work. Together, they trace Tom's match-day disclosure strategy and “find-your-people” approach, an accessibility walk-through with tape measures and ADA checks, and the practical creativity of equivalent rotations when sites differ in accessibility. They also unpack a real barrier—a security policy that blocked ED entry during stroke alerts—and how reframing access as patient safety moved the system. Listeners will hear candid advice for residents (hold onto your “why,” communicate early, invite teaching adaptations) and for program directors (start with goals, not habits; assume success; apply the same creativity you offer patients to your trainees). This episode accompanies a written case study and a Mini Grand Rounds conversation in Learn at ACGME. Part of the ACGME/DWDI Disability Resource Hub, supported by the Josiah Macy Jr. Foundation Catalyst Award, it's a practical guide for PDs, residents, and anyone committed to equitable clinical training.   Transcript: https://docs.google.com/document/d/1xB_Cp8EiekJ9ExUZLP61EvE-0y4HUv22LuRp0D6uNB0/edit?usp=sharing Key words: Medical education, physical disability, disability research, residency, accommodations, wheelchair, SCI, medical technology, residency, neurology, program director, GME, GME Policy Bio: Laura Stein I have been involved in the Neurology Residency Program since 2018, and Director of the program since 2024. I teach residents on multiple inpatient services as well as in outpatient continuity clinic and stroke clinics. I also lead didactic sessions and workshops for resident onboarding and in our resident lecture series. I am particularly interested in expanding resident exposure to structured experiences in medical education and quality improvement and currently mentor multiple residents per year in medical education and quality improvement projects. In 2020, I was honored to receive the University of Pennsylvania Neurology Residents teaching award. I received my masters in medical education from the University of Pennsylvania in 2018. I have been a member of the American Academy of Neurology (AAN) Residency-In-Training Examination Committee since 2019. I have also been a member of the American Heart Association (AHA) Stroke Professional Education Committee since 2016 and currently serve as the Vice Chair of this committee. Clinically, I function predominantly as a neurohospitalist and attend on the stroke inpatient and consult services, the neurology ward service, and the PPMC consult service. I am dedicated to ensuring delivery of high-quality neurologic care across our system and currently am the physician co-lead for our neurovascular disease team, which spans our six-hospital network, as well as our HUP inpatient neurology unit-based quality improvement team. Tom Pisano I enjoy weekend bike rides with my wife, followed by trying out a new restaurant. When traveling, if possible, I always try to get in some monoskiing or scuba diving. I would also consider myself a (very) mildly competitive board gamer. I will be pursuing a combined neurohospitalist/neuroimmunology fellowship to develop expertise in myelopathies. My research includes brain-computer interfaces, especially of the spinal cord. Producer:  Lisa Meeks Follow Us: X: @DocsWith Instagram: @DocsWithDisabilities Linked In: https://www.linkedin.com/company/docs-with-disabilities-initiative Resources:  Disability Resource Hub: https://dl.acgme.org/pages/disability-resource-hub Case Studies in Disability Resource Hub: https://dl.acgme.org/pages/disability-resource-hub#case_studies UME to GME Toolkit:  https://dl.acgme.org/pages/disability-resource-hub-transitions-toolkit-introduction Policy Toolkit: https://dl.acgme.org/pages/disability-resource-hub-policy-toolkit Disability in Graduate Medical Education Program:  https://www.docswithdisabilities.org/digme   Link to Case Study: Coming Soon!              

Drink of the Night: Marker Cellars Red – deep ruby, caramel hints (fight over the pronunciation).The Bros are back, sipping on Marker Cellars red (out of anything but wine glasses, of course) and catching up after a summer hiatus that may or may not have involved Clyde's mysterious vacation. Doc starts slurring his words, one glass in. We wander from wine reviews to war games, from public school rants to homeschooling hacks, and somehow end up debating AI dance teachers and audiobook robot overlords.Highlights in This Episode:

Ready to set your fee? You choose the dream, we'll do the math. Download our FREE Fun with Fees Calculator

For The Other Side NDE Videos Visit ▶️ youtube.com/@TheOtherSideNDEYT Purchase our book on Amazon

What if AI could help schools not just support educators as they work to manage student mental health needs, but prevent crises before they start? In this thought-provoking episode, Dr. Elsa Friis, licensed clinical psychologist from Alongside, returns to discuss how her team is using clinician-built AI tools to support students, educators, and families. From building trust through anonymity to boosting classroom attendance, Elsa shares research, real stories, and the myths she's constantly debunking.

In this episode of The Real Spiritual Talk Podcast, Crystal Johnson describes her battle with COVID-19, which she temporarily succumbed to. While on a ventilator and clinically dead, she leaves this physical realm and is joined by deceased relatives, and learns that life moves beyond this earthly reality.

In 1999, Swedish medical student, Anna Bågenholm, was skiing in Norway with friends when she fell through a frozen stream and became trapped under a thick layer of ice. Unable to free herself, and forced to wait for rescue, her body temperature quickly fell to 13.7°C (56.7°F) and she fell unconscious. 80 minutes later, Bågenholm was brought to the surface by rescuers, clinically dead. But that is not the end of Anna's story... Sources: -Aftonbladet- Her temp was down to 13.8 degrees -Swedish-Norwegian co-operation in the treatment of three hypothermia victims: A case report, Scandinavian Journal of Trauma Resuscitation and Emergency Medicine - Tjugofyra7, Clinically dead but Anna survived – My story can help others -Another Day: Cheating Death To advertise on this podcast please email: ad-sales@libsyn.com    Or go to: https://advertising.libsyn.com/Marooned 

 Normal pressure hydrocephalus (NPH) is a clinical syndrome of gait abnormality, cognitive impairment, and urinary incontinence. Evaluation of CSF dynamics, patterns of fludeoxyglucose (FDG) uptake, and patterns of brain stiffness may aid in the evaluation of challenging cases that lack typical clinical and structural radiographic features. In this episode, Katie Grouse, MD, FAAN, speaks with Aaron Switzer, MD, MSc, author of the article “Radiographic Evaluation of Normal Pressure Hydrocephalus” in the Continuum® June 2025 Disorders of CSF Dynamics issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California San Francisco in San Francisco, California. Dr. Switzer is a clinical assistant professor of neurology in the department of clinical neurosciences at the University of Calgary in Calgary, Alberta, Canada. Additional Resources Read the article: Radiographic Evaluation of Normal Pressure Hydrocephalus Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Grouse: This is Dr Katie Grouse. Today I'm interviewing Dr Aaron Switzer about his article on radiographic evaluation of normal pressure hydrocephalus, which he wrote with Dr Patrice Cogswell. This article appears in the June 2025 Continuum issue on disorders of CSF dynamics. Welcome to the podcast, and please introduce yourself to our audience. Dr. Switzer: Thanks so much for having me, Katie. I'm a neurologist that's working up in Calgary, Alberta, Canada, and I have a special interest in normal pressure hydrocephalus. So, I'm very happy to be here today to talk about the radiographic evaluation of NPH. Dr Grouse: I'm so excited to have you here today. It was really wonderful to read your article. I learned a lot on a topic that is not something that I frequently evaluate in my clinic. So, it's really just a pleasure to have you here to talk about this topic. So, I'd love to start by asking, what is the key message that you hope for neurologists who read your article to take away from it? Dr. Switzer: The diagnosis of NPH can be very difficult, just given the clinical heterogeneity in terms of how people present and what their images look like. And so, I'd like readers to know that detailed review of the patient's imaging can be very helpful to identify those that will clinically improve with shunt surgery. Dr Grouse: There's another really great article in this edition of Continuum that does a really great job delving into the clinical history and exam findings of NPH. So, I don't want to get into that topic necessarily today. However, I'd love to hear how you approach a case of a hypothetical patient, say, where you're suspicious of NPH based on the history and exam. I'd love to talk over how you approach the imaging findings when you obtain an MRI of the brain, as well as any follow-up imaging or testing that you generally recommend. Dr. Switzer: So, I break my approach down into three parts. First, I want to try to identify ventriculomegaly and any signs that would support that, and specifically those that are found in NPH. Secondly, I want to look for any alternative pathology or evidence of alternative pathology to explain the patient's symptoms. And then also evaluate any contraindications for shunt surgery. For the first one, usually I start with measuring Evans index to make sure that it's elevated, but then I want to measure one of the other four measurements that are described in the article, such as posterior colossal angle zed-Evans index---or z-Evans index for the American listeners---to see if there's any other features that can support normal pressure hydrocephalus. It's very important to identify whether there are features of disproportionately enlarged subarachnoid space hydrocephalus, or DESH, which can help identify patients who may respond to shunt surgery. And then if it's really a cloudy clinical picture, it's complicated, it's difficult to know, I would usually go through the full evaluation of the iNPH radscale to calculate a score in order to determine the likelihood that this patient has NPH. So, the second part of my evaluation is to rule out evidence of any alternative pathology to suggest another cause for the patient's symptoms, such as neurodegeneration or cerebrovascular disease. And then the third part of my evaluation is to look for any potential contraindications for shunt surgery, the main one being cerebral microbleed count, as a very high count has been associated with the hemorrhagic complications following shunt surgery. Dr Grouse: You mentioned about your use of the various scales to calculate for NPH, and your article does a great job laying them out and where they can be helpful. Are there any of these scales that can be reasonably relied on to predict the presence of NPH and responsiveness to shunt placement? Dr. Switzer: I think the first thing to acknowledge is that predicting shunt response is still a big problem that is not fully solved in NPH. So, there is not one single imaging feature, or even combination of imaging features, that can reliably predict shunt response. But in my view and in my practice, it's identifying DESH, I think, is really important---so, the disproportionately enlarged subarachnoid space hydrocephalus---as well as measuring the posterior colossal angle. I find those two features to be the most specific. Dr Grouse: Now you mentioned the concept of the NPH subtypes, and while this may be something that many of our listeners are familiar with, I suspect that, like myself when I was reading this article, there are many who maybe have not been keeping up to date on these various subtypes. Could you briefly tell us more about these NPH subtypes? Dr. Switzer: Sure. The Japanese guidelines for NPH have subdivided NPH into three different main categories. So that would be idiopathic, delayed onset congenital, and secondary normal pressure hydrocephalus. And so, I think the first to talk about would be the secondary NPH. We're probably all more familiar with that. That's any sort of pathology that could lead to disruption in CSF dynamics. These are things like, you know, a slow-growing tumor that is obstructing CSF flow or a widespread meningeal process that's reducing absorption of CSF, for instance. So, identifying these can be important because it may offer an alternative treatment for what you're seeing in the patient. The second important one is delayed onset congenital. And when you see an image of one of these subtypes, it's going to be pretty different than the NPH because the ventricles are going to be much larger, the sulcal enfacement is going to be more diffuse. Clinically, you may see that the patients have a higher head circumference. So, the second subtype to know about would be the delayed onset congenital normal pressure hydrocephalus. And when you see an image of one of these subtypes, it's going to be a little different than the imaging of NPH because the ventricles are going to be much larger, the sulcal enfacement is going to be more diffuse. And there are two specific subtypes that I'd like you to know about. The first would be long-standing overt ventriculomegaly of adulthood, or LOVA. And the second would be panventriculomegaly with a wide foramen of magendie and large discernomagna, which is quite a mouthful, so we just call it PAVUM. The importance of identifying these subtypes is that they may be amenable to different types of treatment. For instance, LOVA can be associated with aqueductal stenosis. So, these patients can get better when you treat them with an endoscopic third ventriculostomy, and then you don't need to move ahead with a shunt surgery. And then finally with idiopathic, that's mainly what we're talking about in this article with all of the imaging features. I think the important part about this is that you can have the features of DESH, or you can not have the features of DESH. The way to really define that would be how the patient would respond to a large-volume tap or a lumbar drain in order to define whether they have this idiopathic NPH. Dr Grouse: That's really helpful. And for those of our listeners who are so inclined, there is a wonderful diagram that lays out all these subtypes that you can take a look at. I encourage you to familiarize yourself with these different subtypes. Now it was really interesting to read in your article about some of the older techniques that we used quite some time ago for diagnosing normal pressure hydrocephalus that thankfully we're no longer using, including isotope encephalography and radionuclide cisternography. It certainly made me grateful for how we've come in our diagnostic tools for NPH. What do you think the biggest breakthrough in diagnostic tools that are now clinically available are? Dr. Switzer: You know, definitely the advent of structural imaging was very important for the evaluation of NPH, and specifically the identification of disproportionately enlarged subarachnoid space hydrocephalus, or DESH, in the late nineties has been very helpful for increasing the specificity of diagnosis in NPH. But some of the newer technologies that have become available would be phase-contrast MRI to measure the CSF flow rate through the aqueduct has been very helpful, as well as high spatial resolution T2 imaging to actually image the ventricular system and look for any evidence of expansion of the ventricles or obstruction of CSF flow. Dr Grouse: Regarding the scales that you had referenced earlier, do you think that we can look forward to more of these scales being automatically calculated and reported by various software techniques and radiographic interpretation techniques that are available or going to be available? Dr. Switzer: Definitely yes. And some of these techniques are already in development and used in research settings, and most of them are directed towards automatically detecting the features of DESH. So, that's the high convexity tight sulci, the focally enlarged sulci, and the enlarged Sylvian fissures. And separating the CSF from the brain tissue can help you determine where CSF flow is abnormal throughout the brain and give you a more accurate picture of CSF dynamics. And this, of course, is all automated. So, I do think that's something to keep an eye out for in the future. Dr Grouse: I wanted to ask a little more about the CSF flow dynamics, which I think may be new to a lot of our listeners, or certainly something that we've only more recently become familiar with. Can you tell us more about these advances and how we can apply this information to our evaluations for NPH? Dr. Switzer: So currently, only the two-dimensional phase contrast MRI technique is available on a clinical basis in most centers. This will measure the actual flow rate through the cerebral aqueduct. And so, in NPH, this can be elevated. So that can be a good supporting marker for NPH. In the future, we can look forward to other techniques that will actually look at three-dimensional or volume changes over time and this could give us a more accurate picture of aberrations and CSF dynamics. Dr Grouse: Well, definitely something to look forward to. And on the topic of other sort of more cutting-edge or, I think, less commonly-used technologies, you also mentioned some other imaging modalities, including diffusion imaging, intrathecal gadolinium imaging, nuclear medicine studies, MR elastography, for example. Are any of these modalities particularly promising for NPH evaluations, in your opinion? Do you think any of these will become more popularly used? Dr. Switzer: Yes, I think that diffusion tract imaging and MR elastography are probably the ones to keep your eye out for. They're a little more widely applicable because you just need an MR scanner to acquire the images. It's not invasive like the other techniques mentioned. So, I think it's going to be a lot easier to implement into clinical practice on a wide scale. So, those would be the ones that I would look out for in the future. Dr Grouse: Well, that's really exciting to hear about some of these techniques that are coming that may help us even more with our evaluation. Now on that note, I want to talk a little bit more about how we approach the evaluation and, in your opinion, some of the biggest pitfalls in the evaluation of NPH that you've found in your career. Dr. Switzer: I think there are three of note that I'd like to mention. The first would be overinterpreting the Evans index. So, just because an image shows that there's an elevated Evans index does not necessarily mean that NPH is present. So that's where looking for other corroborating evidence and looking for the clinical features is really important in the evaluation. Second would be misidentifying the focally enlarged sulci as atrophy because when you're looking at a brain with these blebs of CSF space in different parts of the brain, you may want to associate that to neurodegeneration, but that's not necessarily the case. And there are ways to distinguish between the two, and I think that's another common pitfall. And then third would be in regards to the CSF flow rate through the aqueduct. And so, an elevated CSF flow is suggestive of NPH, but the absence of that does not necessarily rule NPH out. So that's another one to be mindful of. Dr Grouse: That's really helpful. And then on the flip side, any tips or tricks or clinical pearls you can share with us that you found to be really helpful for the evaluation of NPH? Dr. Switzer: One thing that I found really helpful is to look for previous imaging, to look if there were features of NPH at that time, and if so, have they evolved over time; because we know that in idiopathic normal pressure hydrocephalus, especially in the dash phenotype, the ventricles can become larger and the effacement of the sulci at the convexity can become more striking over time. And this could be a helpful tool to identify how long that's been there and if it fits with the clinical history. So that's something that I find very helpful. Dr Grouse: Absolutely. When I read that point in your article, I thought that was really helpful and, in fact, I'm guessing something that a lot of us probably aren't doing. And yet many of our patients for one reason or other, probably have had imaging five, ten years prior to their time of evaluation that could be really helpful to look back at to see that evolution. Dr. Switzer: Yes, absolutely. Dr Grouse: It's been such a pleasure to read your article and talk with you about this today. Certainly a very important and helpful topic for, I'm sure, many of our listeners. Dr. Switzer: Thank you so much for having me. Dr Grouse: Again, today I've been interviewing Dr Aaron Switzer about his article on radiographic evaluation of normal pressure hydrocephalus, which he wrote with Dr Patrice Cogswell. This article appears in the most recent issue of Continuum on disorders of CSF dynamics. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Why is it still so hard to just be in your own skin when you're a gay Latinx man? From religious guilt to macho pressure, the layers of shame and silence can run deep. In this episode, therapist and NYU instructor Lucas Saiter joins us to unpack the mental health challenges gay Latinx men face—and how we can finally stop carrying everyone else's expectations. Lucas brings powerful insight as a clinician, Latinx gay man, and community builder. From healing identity wounds to rebuilding intimate connections, he's helping men take off the mask and find real belonging—in themselves and in their communities. If you've ever felt like you're too much or not enough, this one's for you. In this episode we: Learn how to close the gap between shame and self-lov Break the patterns of it being rude or disrespectful to discuss mental health in the Latinx world Discover how vulnerability is a superpower About Lucas Lucas Saiter is the founder and director of Manhattan Therapy NYC and Adjunct Instructor in the Department of Applied Psychology at NYU. In addition to working in a group practice in New York City, he also maintains his own private practice, supervising recent graduates obtaining hours for licensure. Clinically he has interests in many areas, including LGBTQIA+ individuals working on strengthening identity, Latinx individuals and couples, immigrants adjusting to living in NYC, adults and young adults dealing with anxiety, depression, identity concerns, trauma, and relationship and intimacy concerns. Connect With Lucas Website Hey Guys, Check This Out! Are you a guy who keeps struggling to do that thing? You know the thing you keep telling yourself and others you're going to do, but never do? Then it's time to get real and figure out why. Join the 40 Plus: Gay Men Gay Talk, monthly chats. They happen the third Monday of each month at 5:00 pm Pacific - Learn More! Also, join our Facebook Community - 40 Plus: Gay Men, Gay Talk Community Break free of fears. Make bold moves. Live life without apologies

Anna Lee Stone is a psychology instructor at Beverly Hills Design Institute and The School for Young Performers. She holds a bachelor of science in general education and psychology and a master of science in interdisciplinary studies with a dual focus on educational design and professional communications from Southern Utah University. Anna is currently working towards her second master's degree in consciousness and transformative studies at JFKU while concurrently enrolled at the University of Sedona as a Ph.D. candidate in transpersonal psychology.Her previous publications include “ACE and the Impact on Learning,” “Teacher Stress During the COVID-19 Pandemic”, and “Trauma, Initiation, and the Wounded Healer”. Anna's own history of childhood trauma and her struggle with accepting her psychic gifts, and her near-death event in 2016 are the driving forces behind her research into childhood trauma and its links to psychic abilities. Anna has two daughters, 26 and 8, and lives in Los Angeles, CA.Please enjoy my conversation with Anna Lee Stone.Become a supporter of this podcast: https://www.spreaker.com/podcast/next-level-soul-podcast-with-alex-ferrari--4858435/support.

Elon Musk is going nuclear—not on the Left, but on Republicans. He's threatening to primary GOP lawmakers and float a third party, fracturing MAGA. I'll show you why this could be the exact setup that hands the next midterm election back to the Left—and how we stop it. Today's Sponsor Multi Collagen Advanced Longevity.† Clinically studied superfoods support cellular energy,† radiant skin† and flexible joints† to help you feel younger and more vibrant. LanceWallnau.com/Renew  

In this week's episode, Dr. Fiona Lovely speaks with Gerardo Gutierrez - “Guti”, founder of Mitolux, about one of the most overlooked pillars of wellness: sunlight. After facing pre-diabetes, low testosterone, and depression, Gerardo turned away from lifelong medications and toward natural healing. His recovery began with daily sun exposure—a simple shift that dramatically improved his hormone levels, mood, and overall vitality. Gerardo now educates others on the science of light: how UVB, red, and infrared wavelengths support vitamin D production, hormone balance, mental clarity, and even skin health. He also shares why he created the Mitolux lamp—to help people safely access the benefits of sunlight indoors, especially in modern lifestyles that keep us indoors and afraid of the sun. If you've ever wondered whether sunlight could be more healing than harmful, this episode is a must-listen. Topics We Cover in This Episode: How Guti reversed chronic health issues using sunlight instead of pharmaceuticals Why UVB, red, and infrared light are essential for hormone health, energy, and mood The truth about sunscreen and how some types can disrupt hormones How light therapy supports skin, collagen, anti-aging, and even libido Why Mitolux was born—to safely replicate the sun's full healing spectrum at home You can learn more at Mitolux.com,  and please follow Guti on Instagram @mitoluxusa.   Thank you to our sponsors for this episode:

When formula shelves went empty in 2022, clinicians scrambled. Desperate parents, unfamiliar brands, and European imports raised more questions than answers. Since January 2024, one name kept coming up: Kabrita.Is goat milk-based formula just a trend—or is it a clinically sound option you can recommend with confidence?In this episode, sponsored by Kabrita, I'm joined by Dr. Ari Brown, board-certified pediatrician, bestselling author of the Baby 411 series, and Kabrita's Chief Medical Advisor. We break down what makes goat milk-based infant formula different from cow's milk-based infant formula—and why it might be a better fit for some babies.What You'll Learn:How goat milk-based infant formula supports digestion and tolerance compared to cow milk-based formulaThe fussy-but-not-allergic infant: when goat milk-based infant formula may be worth tryingWhat to say to parents asking about European imports or formula intoleranceWhy goat milk-based infant formula deserves consideration as a first-line optionWhether you're seeing fussy infants, overwhelmed parents, or simply want to expand your nutrition knowledge, this episode will help you feel more confident navigating today's infant formula landscape.Resources:Download the comprehensive formula feeding eBook adapted from the bestselling book, Baby 411 by Ari Brown, MD, FAAP! Unlock evidence-based insights, best practices, key differences between cow, goat, and soy-based infant formulas, and more. https://eu1.hubs.ly/H0klJHr0 Any Questions? Send Me a MessageSupport the showConnect with Colleen:InstagramLinkedInSign up for my FREE Newsletter - Nutrition hot-topics delivered to your inbox each week. Disclaimer: This podcast is a collection of ideas, strategies, and opinions of the author(s). Its goal is to provide useful information on each of the topics shared within. It is not intended to provide medical, health, or professional consultation or to diagnosis-specific weight or feeding challenges. The author(s) advises the reader to always consult with appropriate health, medical, and professional consultants for support for individual children and family situations. The author(s) do not take responsibility for the personal or other risks, loss, or liability incurred as a direct or indirect consequence of the application or use of information provided. All opinions stated in this podcast are my own and do not reflect the opinions of my employer.

In this week's episode,  Dr. Fiona Lovely speaks with Cathy Eason, a certified holistic nutritionist and clinical educator, about nitric oxide (NO), often called the "miracle molecule" for its vital role in blood flow and thus, overall health.  We talk about the groundbreaking findings from a pilot study on nitric oxide's impact on women's sexual health, revealing significant improvements in desire (75%), lubrication (58%), orgasm (83%), and reduced discomfort (83%) among participants who took two capsules of nitric oxide daily for 60 days. Beyond sexual function, we discuss optimal blood flow, facilitated by nitric oxide, which is essential for nutrient and oxygen delivery, waste removal, and hormone transmission throughout the body. Cathy Eason explains that nitric oxide levels naturally decline by about 50% by age 40, which is concerning for women during perimenopause and menopause.  It impacts cardiovascular health, brain function, and energy levels. You can boost your nitric oxides by eating foods like leafy greens and the Berkeley Life supplements, along with practices like nostril breathing and exercise, can support its production. Cathy shares how to use the Berkley Life test strips which offer a practical way to monitor personal nitric oxide levels. Cathy also shares her personal experience using nitric oxide to support her in recovery from mold exposure, noting its benefits for detox, cellular energy, and immune system health. You can learn more about Cathy Eason through her LinkedIn profile, or explore her work with Berkeley Life, a company focused on stress resilience and nitric oxide-boosting supplements. Thank you to our sponsors for this episode:

In this episode, Mohamed welcomes back Dr. Kevin Harland, a recent graduate from the OU College of Dentistry, for a candid conversation about the realities of life just two years out of dental school. Dr. Harland shares a powerful personal story about his daughter's health journey, which profoundly reshaped his perspective on his career and life. He then offers invaluable advice for fourth-year dental students, covering everything from tackling board exams and the importance of gaining hands-on clinical experience to the nuances of treatment planning and material selection. Dr. Harland also discusses the benefits of joining a professional study club and shares what motivates him daily as he navigates the challenges and rewards of his growing career. A New Perspective: Dr. Harland opens up about his daughter's recent major surgery and recovery, a life-altering experience that helped him prioritize his family and find a deeper meaning in his work. Board Exam Tips: For fourth-year students, Dr. Harland advises using question banks like Bootcamp for the INBDE and getting comfortable with plastic teeth for the clinical boards, emphasizing that these exams don't define your career. Fourth-Year Focus: He recommends that fourth-year students should start thinking seriously about their desired work environment by shadowing in various practices (DSO, private practice, public health). Clinically, the focus should be on getting comfortable with the handpiece and experimenting with different materials and techniques in the safe environment of the dental school. Clinical Growth: Dr. Harland's biggest areas of growth have been in the efficiency and confidence of his handpiece skills and in the complexities of treatment planning, especially when dealing with difficult cases. Navigating Difficult Conversations: He emphasizes the importance of under-promising and over-delivering, and having honest conversations with patients about the possibility of different treatment outcomes. The Value of Community: Dr. Harland shares his positive experience with a local study club, highlighting the camaraderie and the invaluable access to a collective mind of experienced clinicians. Materials Matter: He discusses his material selection for partial and full crowns, weighing the pros and cons of materials like EMAX, Tetric CAD, and Zirconia based on the clinical situation. Daily Motivation: Dr. Harland finds motivation in providing for his family, the satisfaction of creating excellent restorations, and the positive feedback from patients who recognize his care and dedication. Join the Very Dental Facebook group using the password "Timmerman," Hornbrook" or "McWethy," "Papa Randy" or "Lipscomb!" The Very Dental Podcast network is and will remain free to download. If you'd like to support the shows you love at Very Dental then show a little love to the people that support us! -- Crazy Dental has everything you need from cotton rolls to equipment and everything in between and the best prices you'll find anywhere! If you head over to verydentalpodcast.com/crazy and use coupon code “VERYDENTAL10” you'll get another 10% off your order! Go save yourself some money and support the show all at the same time! -- The Wonderist Agency is basically a one stop shop for marketing your practice and your brand. From logo redesign to a full service marketing plan, the folks at Wonderist have you covered! Go check them out at verydentalpodcast.com/wonderist! -- Enova Illumination makes the very best in loupes and headlights, including their new ergonomic angled prism loupes! They also distribute loupe mounted cameras and even the amazing line of Zumax microscopes! If you want to help out the podcast while upping your magnification and headlight game, you need to head over to verydentalpodcast.com/enova to see their whole line of products! -- CAD-Ray offers the best service on a wide variety of digital scanners, printers, mills and even  their very own browser based design software, Clinux! CAD-Ray has been a huge supporter of the Very Dental Podcast Network and I can tell you that you'll get no better service on everything digital dentistry than the folks from CAD-Ray. Go check them out at verydentalpodcast.com/CADRay!    

In this week's episode, Dr. Joy Kong shares her pioneering work in stem cell therapy and regenerative medicine. From reversing signs of aging to offering hope for chronic conditions, Dr. Kong explains how ethically sourced umbilical cord-derived stem cells act as the body's ultimate repair crew. She shares a moving case study of a child with autism who experienced life-changing improvements after stem cell therapy, and breaks down why we lose stem cells as we age—and what we can do to replenish them. Dr. Kong also talks about how this cutting-edge science supports women in midlife, with benefits for hormonal balance, cognitive function, and vitality. She even gives us a peek into her personal anti-aging routine, including her potent stem cell skincare line and regular IV infusions. If you're curious about the future of longevity, disease prevention, and rewriting the rules of aging, this episode is for you. What You'll Hear: ✨ How umbilical cord-derived stem cells regenerate tissues and calm inflammation ✨ A powerful autism case study that shows real-world results ✨ Why stem cells decline as we age—and how replenishing them can prevent chronic decline ✨ How to ensure stem cell sources are ethical and safe ✨ Dr. Kong's personal anti-aging protocol, from IV therapy to skincare ✨ The emerging promise of stem cells for menopause and healthy aging Find more about Dr. Kong here

Tune in to episode 65 of Body Justice to hear our thoughts on decolonization and eating disorders. This was a fun and insightful reverse interview with a friend and colleague, Shikha Advani. Shikha is deeply committed to social justice in eating disorder treatment and it was an honor to be apart of her research project.From Shikha: Hi! I'm Shikha Advani, a doctoral student at the University of Denver's Graduate School of Social Work. I hold master's degrees in nutrition and social work, and my research focuses on eating disorders, weight stigma, and decolonization. Clinically, I work as an eating disorder therapist supporting individuals with complex trauma and marginalized identities. I aim to bridge clinical and research worlds to promote anti-oppression and decolonial practices in the ED field. Outside of work, I love spending time with my cat Jellybean, reading, and trying new food.As always, you can find me on IG @bodyjustice.therapist and my website www.eatingdisorderocdtherapy.comPlease know that this podcast is for educational purposes only and is not meant for individual health or therapeutic advice. Listening to this podcast does not constitute a provider-patient relationship.

Welcome to the "Week in Review," where we delve into the true stories behind this week's headlines. Your host, Tony Brueski, joins hands with a rotating roster of guests, sharing their insights and analysis on a collection of intriguing, perplexing, and often chilling stories that made the news.       This is not your average news recap. With the sharp investigative lens of Tony and his guests, the show uncovers layers beneath the headlines, offering a comprehensive perspective that traditional news can often miss. From high-profile criminal trials to in-depth examinations of ongoing investigations, this podcast takes listeners on a fascinating journey through the world of true crime and current events.       Each episode navigates through multiple stories, illuminating their details with factual reporting, expert commentary, and engaging conversation. Tony and his guests discuss each case's nuances, complexities, and human elements, delivering a multi-dimensional understanding to their audience.  Whether you are a dedicated follower of true crime, or an everyday listener interested in the stories shaping our world, the "Week in Review" brings you the perfect balance of intrigue, information, and intelligent conversation. Expect thoughtful analysis, informed opinions, and thought-provoking discussions beyond the 24-hour news cycle. Want to comment and watch this podcast as a video?  Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

Welcome to the "Week in Review," where we delve into the true stories behind this week's headlines. Your host, Tony Brueski, joins hands with a rotating roster of guests, sharing their insights and analysis on a collection of intriguing, perplexing, and often chilling stories that made the news.       This is not your average news recap. With the sharp investigative lens of Tony and his guests, the show uncovers layers beneath the headlines, offering a comprehensive perspective that traditional news can often miss. From high-profile criminal trials to in-depth examinations of ongoing investigations, this podcast takes listeners on a fascinating journey through the world of true crime and current events.       Each episode navigates through multiple stories, illuminating their details with factual reporting, expert commentary, and engaging conversation. Tony and his guests discuss each case's nuances, complexities, and human elements, delivering a multi-dimensional understanding to their audience.  Whether you are a dedicated follower of true crime, or an everyday listener interested in the stories shaping our world, the "Week in Review" brings you the perfect balance of intrigue, information, and intelligent conversation. Expect thoughtful analysis, informed opinions, and thought-provoking discussions beyond the 24-hour news cycle. Want to comment and watch this podcast as a video?  Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

Inside Diddy's Freak-Offs: Five Clinically Disturbing Details Dive deep into the unsettling courtroom revelations about Sean "Diddy" Combs' infamous "freak-offs" with psychotherapist Shavaun Scott. Shavaun analyzes five clinically disturbing details from testimony given by exotic dancer Sharay "The Punisher" Hayes, who described secretive and controlled sexual encounters arranged by Combs. From concealed identities and voyeuristic behavior to ritualistic power dynamics involving strict instructions and unusual props like warmed baby oil, this video sheds light on the psychological implications of such disturbing behavior. What drives someone to engage in hidden, controlling, and ritualized sexual behaviors? Shavaun offers professional insights into power, consent, secrecy, shame, and the potentially dangerous psychological impulses underlying these acts. This exploration into Combs' secretive world offers chilling yet important understandings for anyone intrigued by celebrity scandals and the psychology behind troubling behaviors. Hashtags: #DiddyTrial #FreakOffs #TrueCrimeCommunity #PsychologicalAnalysis #CelebritySecrets #CoerciveBehavior #SharayHayes #SexualPsychology #HiddenKillersPodcast #CrimeInsights Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

Inside Diddy's Freak-Offs: Five Clinically Disturbing Details Dive deep into the unsettling courtroom revelations about Sean "Diddy" Combs' infamous "freak-offs" with psychotherapist Shavaun Scott. Shavaun analyzes five clinically disturbing details from testimony given by exotic dancer Sharay "The Punisher" Hayes, who described secretive and controlled sexual encounters arranged by Combs. From concealed identities and voyeuristic behavior to ritualistic power dynamics involving strict instructions and unusual props like warmed baby oil, this video sheds light on the psychological implications of such disturbing behavior. What drives someone to engage in hidden, controlling, and ritualized sexual behaviors? Shavaun offers professional insights into power, consent, secrecy, shame, and the potentially dangerous psychological impulses underlying these acts. This exploration into Combs' secretive world offers chilling yet important understandings for anyone intrigued by celebrity scandals and the psychology behind troubling behaviors. Hashtags: #DiddyTrial #FreakOffs #TrueCrimeCommunity #PsychologicalAnalysis #CelebritySecrets #CoerciveBehavior #SharayHayes #SexualPsychology #HiddenKillersPodcast #CrimeInsights Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

For The Other Side NDE Videos Visit ▶️ youtube.com/@TheOtherSideNDEYT Purchase our book on Amazon

We unpack the clinical pearls and evidence-based strategies behind:

Jenny Hughes, PhD is a licensed clinical psychologist specializing in trauma and PTSD. As the founder of  The BRAVE Trauma Therapist Collective, Jenny helps trauma therapists be human again as they learn how to manage vicarious trauma and enhance vicarious resilience together. Clinically, she practices Brainspotting, EMDR, and Cognitive Processing Therapy. Jenny is the author of The PTSD Recovery Workbook and Triggers to Glimmers: A Vicarious Resilience Journal and Workbook.Cesilia is a Licensed Professional Counselor and Brainspotting Consultant and Trainer. She was recently named the first Bilingual (Spanish) Latinx Brainspotting Trainer in the USA. She hosts and facilitates a quarterly free Brainspotting support group for bilingual clinicians nationwide. Her clinical specialties include working with trauma, performance, kids, group therapy, and the Latinx community. In addition to Brainspotting, Cesilia's trainings include IFS, EMDR, and Theraplay. As a private practice clinician, she offers bilingual (English/Spanish) and bi-cultural psychotherapy and consultation. In This EpisodeLearn more about Cesilia at growingmindfulpsychotherapy.comLearn more about Jenny and BRAVE at braveproviders.com---If you'd like to support The Trauma Therapist Podcast and the work I do you can do that here with a monthly donation of $5, $7, or $10: Donate to The Trauma Therapist Podcast.Click here to join my email list and receive podcast updates and other news.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-trauma-therapist--5739761/support.